Lymph chylomicrons radiolabelled in triacylglycerol and cholesteryl ester were injected into control and Watanabe heritable-hyperlipidaemic (WHHL) rabbits. Clearance of chylomicrons was slower in heterozygote and homozygote WHHL rabbits. Slower remnant clearance in WHHL rabbits was confirmed by monitoring the clearance from plasma of preformed chylomicron remnants. Use of chylomicron-like lipid emulsions injected into control and WHHL rabbits also confirmed the defect in remnant clearance in heterozygote WHHL and homozygote WHHL groups. Clearance from plasma of emulsion triolein was delayed in both WHHL groups compared with controls, owing to slower remnant clearance. The clearance from plasma of radioiodinated rabbit low-density lipoproteins (LDL) in heterozygote WHHL rabbits was the same as control rabbits. Defective chylomicron-remnant removal but normal LDL clearance in the heterozygote WHHL corresponded to elevated concentrations of plasma triacylglycerol and normal concentrations of plasma cholesterol. Receptor versus non-receptor clearances of chylomicron remnants were studied by comparing the clearance of emulsions with and without unesterified cholesterol respectively. Unlike control rabbits, there were no significant differences in the clearances of the two emulsion types in either the homozygote or heterozygote WHHL rabbits, indicating that the apolipoprotein-B100/E receptor is the primary route for clearance of chylomicron remnants from plasma.
INTRODUCTION
The clearance of chylomicron remnants from plasma has been postulated to occur via a receptor-mediated process that is distinct from the removal of low-density lipoproteins (LDL) by the apolipoprotein-Bl00/E receptor (LDL receptor). Present understanding is based mainly on a report by Kita et al. [1] , who found that the disappearance of injected radiolabelled chylomicrons from the plasma fraction of density less than 1.006 g/ml was similar in homozygote Watanabe heritable-hyperlipidaemic (WHHL) rabbits (which lack functional LDL receptors) and normal rabbits.
The removal of chylomicron remnants is by a receptormediated process which recognizes apolipoprotein E as the ligand [2] . In contrast, apolipoprotein B0oo is responsible for the binding and uptake of LDL by the apolipoprotein-B100/E receptor. Despite a number of studies in vivo and in vitro, a putative second receptor that binds chylomicron-remnant apolipoprotein E and mediates cellular uptake has not been confidently identified. In contrast, there is evidence to suggest that chylomicron remnants may be removed via the apolipoprotein-Bl00/E receptor. Human fibroblasts take up chylomicron remnants via the apolipoprotein-Bl00/E receptor [3] . The binding of chylomicron remnants to human HepG2 cells, rat liver cells in primary cultures and mouse macrophages was inhibited by [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] % by specific anti-(apolipoprotein-Bl00/E receptor) antibodies or LDL [4] [5] [6] . Chylomicron remnants, LDL and antibodies (apolipoprotein-B100/E receptor) bind to the same proteins of rat liver membrane preparations [7] and mouse macrophages [6] . Furthermore, chylomicron-remnant binding to homozygote WHHL rabbit liver membranes was found to be markedly deficient [1] .
Utilizing lipid emulsions which are similar in size and lipid composition to lymph chylomicrons, we recently showed that the removal of chylomicroh-like emulsion particles from the plasma of homozygote WHHL rabbits was delayed compared with normal rabbits [8] . Chylomicron-like emulsions were also cleared at a slower rate in cholesterol-fed rabbits [8] , where apolipoprotein-B100/E receptor activity is decreased [9] .
The heterozygous form of familial hypercholesterolaemia is the most prevalent genetic lipid disorder of man [10] . WHHL rabbits are a model for this disease. Our data suggest that defective clearance of chylomicron remnants should be expected in heterozygous familial hypercholesterolaemia.
MATERIALS AND METHODS Animals
Heterozygote WHHL rabbits were bred from homozygote bucks and British half-lop does. Rabbits were kept in individual cages and allowed free access to standard chow and water. Rabbits were used between 3 and 11 months of age, and body weight was 2.28-4.80 kg.
Chylomicron-like lipid emulsion
Lipid emulsions resembling chylomicrons in composition and size were prepared as previously described [11] . Mixtures of purified lipids were sonicated in Hepes buffer. Emulsion particles of the required composition and size (100-150 nm) were isolated by sequential gradient ultracentrifugation. Emulsion-particle size was determined with an automated particle sizer (Brookhaven Instruments Corp., New York, NY; U.S.A.) and confirmed by electron microscopy.
Emulsion particles used to monitor receptor-independent removal were modified by omitting unesterified cholesterol [12] . [13] . Lymph chylomicrons were collected via a cannula placed in the mesenteric lymph duct into tubes containing EDTA (5 mM). Lymph was removed from cells by centrifugation at 2000 g for 10 min. Chylomicrons were isolated by densitygradient ultracentrifugation [14] . Chylomicron diameter measured by electron microscopy had a mean of 110-120 nm.
Chylomicron-remnant formation
Chylomicron remnants were prepared as described previously [15] . Approx. 10 mg of chylomicron triacylglycerol was injected into rats which had their liver functionally excluded. Rats were bled 30 min after chylomicron injection, and remnants were isolated by density-gradient ultracentrifugation of the plasma [14] .
LDL isolation and radiolabelling
Rabbit blood was collected by cardiac puncture from normal rabbits anaesthetized with ether. Plasma was separated by lowspeed centrifugation and the density adjusted to 1.020 g/ml by addition of solid KBr. Plasma was centrifuged at 105000 ga, for 24 h at 4°C in a Beckman SW28 rotor. The bottom two-thirds of each tube was collected and the density adjusted to 1.063 g/ml. The infranatant was overlayered with Tris buffer (pH 7) of density 1.063 g/ml. LDL was isolated by ultracentrifugation at 105000 gay, for 22 h in a Beckman SW28 rotor. The LDL was washed by overlaying with at least 9 vol. of Tris buffer (pH 7) of equivalent density and centrifuging at 205000 gav for 22 h in a Beckman SW41 rotor. The purity of the LDL fraction was confirmed by agarose-gel electrophoresis.
LDL was dialysed with multiple changes of 0.15 M-NaCl (pH 7.4) followed by 0.1 M-sodium borate at pH 8.4. Up to 3 mg of LDL in borate buffer (pH 8.4) was radiolabelled with 1 mCi of 1251 directly in lodo-Gen-coated tubes (Pierce Chemical Co., Rockford, IL, U.S.A.). Over 97 % of free 125I was removed by passage through a Sephadex G-25 (fine grade) column, followed by extensive dialysis against 0.15 M-NaCl. Radiolabelled LDL was characterized on the basis ofestablished procedures described by others [16, 17] . Less chylomicron experiments, radioactivity in 400 ,u1 samples of plasma was determined by liquid-scintillation counting in a toluene-based fluor in dual-label mode with auto quench correction (Beckman LS3800 liquid-scintillation counter). For LDL clearance rates, 500,ul of plasma was counted directly for radioactivity in a Packard Auto Gamma scintillation spectrometer (model 5320). Clearance of emulsion or chylomicron lipid was monoexponential over 3-15 min. The fractional clearance rate (FCR) was calculated for this time period by least-squares regression analysis. LDL clearance rates were calculated by using the twopool model described by Matthews [18] . Total rabbit plasma volume was assumed to be 3.3 % of rabbit body weight.
Lipid analysis
Plasma triacylglycerol, free cholesterol, cholesteryl ester and HDL free and esterified cholesterol were determined with Boehringer test kits (nos. 877557, 237574, 310328 and 543004 respectively).
Statistical analysis
The concentrations ofplasma lipids and the rates of lipoprotein clearance were compared between normal and WHHL rabbits by one-way analysis of variance. Significance was accepted for probabilities less than 5 %.
RESULTS
The plasma lipid concentrations for normal rabbits and heterozygote and homozygote WHHL rabbits are given in Table  1 . The homozygote WHHL rabbits had higher concentrations of triacylglycerol, free cholesterol and cholesteryl ester compared with normal control rabbits and heterozygote WHHL rabbits. Triacylglycerol and total cholesterol were increased in similar proportion, both being about 8-fold more than in the control group. In contrast, in the heterozygote WHHL rabbits plasma triacylglycerol was significantly increased, but the free and esterified cholesterol concentrations were similar to those of the control group. The homozygote WHHL rabbits had significantly less HDL cholesterol and HDL triacylglycerol than did either the control group or the heterozygote WHHL rabbits.
The clearance of chylomicron-like emulsion from the plasma of normal and WHHL rabbits is shown in Fig. 1 Clearance from rabbit plasma of rat chylomicrons endogenously radiolabelled with triacylglycerol and cholesteryl ester is shown in Fig. 2 . More radioactivity remained in plasma for both lipids in the homozygote and heterozygote WHHL rabbits compared with the control group. By 3 min after injection, about 20 % of the triacylglycerol component remained in the plasma of control rabbits, about 40 % in the heterozygote and about 80(% in the homozygote WHHL rabbits. Similarly, in the control rabbits 75 % of cholesteryl ester was removed 3 min after chylomicron injection, whereas only 45 % and 20 % ofcholesteryl ester was removed in heterozygote and homozygote WHHL rabbits respectively. The FCRs for lymph chylomicron triacylglycerol and cholesteryl ester are given in Table 3 . By analogy with the chylomicron-like emulsions, both triacylglycerol and cholesteryl ester were cleared at progressively slower rates in the heterozygote and homozygote WHHL rabbits compared with controls.
To clarify that slow chylomicron-remnant removal in WHHL rabbits was not due to slow formation of remnants in vivo (i.e. slow lipolysis of chylomicron triacylglycerol), we monitored the clearance of preformed remnants (Fig. 3) . Normal rabbits cleared preformed chylomicron remnants much faster than did the homozygote WHHL rabbits. The FCR of cholesteryl ester was 0.088+0.010 min-and 0.016+0.007 min-for control and homozygote WHHL rabbits respectively (P < 0.001). In normal rabbits, the rate of triacylglycerol clearance was the same as particle ( Fig. 4 . LDL clearance in normal rabbits and heterozygote WHHL and homozygote WHHL rabbits Rabbit LDL was isolated from plasma of normal rabbits. The LDL was radiolabelled with 125I as described in the Materials and methods section and then injected into conscious normal, heterozygote WHHL and homozygote WHHL rabbits. LDL clearance from plasma is shown as the amount of radioactivity remaining in plasma of control rabbits (0), heterozygote WHHL (0) and homozygote WHHL (El) rabbits. Radioactivity in plasma is given as a percentage of the dose injected. The data are means for 5 normal rabbits, 6 heterozygote WHHL rabbits or 1 homozygote WHHL rabbit. Bars represent S.E.M. and 0.087+0.010 min-' respectively. In homozygote rabbits clearance of triacylglycerol was faster than of cholesteryl ester (0.034+0.008 min-1). It may be that, because the remnants are removed less readily in the WHHL rabbits, further lipolysis of particle triacylglycerol is able to occur.
The clearance of LDL in rabbits is presented in Fig. 4 . The pattern of removal was bi-exponential. In homozygote WHHL rabbits, there was no rapid removal phase, and the amount of radiolabelled LDL remaining in plasma with time was much higher than in control rabbits. The FCR in the homozygote WHHL rabbit was 0.032 h-. In contrast, clearance rates of radiolabelled LDL from plasma of heterozygote WHHL rabbits and controls were similar and much faster, 0.185 + 0.033 h-I and 0.199 + 0.037 h-1 respectively (means + S.E.M.).
The clearances of chylomicron-like emulsions with or without cholesterol were compared in the same rabbit on consecutive days. Clearance patterns of the two emulsion types in normal and WHHL rabbits are shown in Fig. 5 . Triacylglycerol removal was similar for the two emulsions in normal and WHHL rabbits (Table 4) . Clearance ofemulsion containing cholesterol in normal rabbits was rapid and exponential in nature. In emulsion lacking cholesterol, removal was very slow, being less than 3 % as rapid as for normal emulsion. The clearances from plasma of cholesterol-free remnants were similar for the control rabbits and the two WHHL groups (Fig. 5) . The difference between total rates of clearance (emulsion containing unesterified cholesterol) and receptor-independent removal (emulsion lacking unesterified cholesterol) was substantial in the control rabbits, but not different in the heterozygote and homozygote WHHL rabbits.
DISCUSSION
The clearance from plasma of chylomicron-like emulsion remnants is impaired in homozygote WHHL rabbits [8] , presumably owing to the lack of functioning apolipoprotein-B100/E receptors. In humans, an absolute deficiency of the LDL receptor (homozygote familial hypercholesterolaemia) is rare, and so perhaps of more importance is how heterozygotes of familial Chylomicron-like emulsion containing radiolabelled cholesteryl oleate was prepared as described in the Materials and methods section. Removal of this emulsion in conscious control rabbits and heterozygote WHHL and homozygote WHHL rabbits was compared on consecutive days with that of a second emulsion which lacked unesterified cholesterol. The amount of radiolabelled cholesterol oleate remaining in plasma is shown as a percentage of the dose injected for emulsion containing unesterified cholesterol (0) and emulsion lacking unesterified cholesterol (-) in each group of rabbits. Data are means for two rabbits per treatment, and bars represent the range. Table 4 . Clearance of chylomicron-like emulsion and cholesterol-free emulsion in normal control rabbits and heterozygote WHHL and homozygote WHHL rabbits
Chylomicron-like lipid particles were prepared as described in the Materials and methods section. In a second emulsion type unesterified cholesterol was omitted from the preparation. Both cholesterol-containing and cholesterol-free emulsions contained radiolabelled triolein and radiolabelled cholesteryl oleate, a different radioisotope being used for each lipid. The two emulsions were injected on consecutive days into a lateral ear vein of conscious rabbits. Clearance rates for emulsion triolein and cholesteryl oleate were calculated from the amount of radioactivity remaining in plasma with time for the two radioisotopes respectively. Cholesteryl oleate reflects receptor-mediated uptake. Triolein removal is by lipolysis and particle uptake. Data are means + range for two rabbits per treatment. The differences between columns (1) and (3) and columns (2) and (4) [20] . Therefore, chylomicron remnants are not exposed to the Vol. 276 between the two lipoprotein types, the apolipoprotein-Bl00/E receptor binds lipoprotein via apolipoprotein E with high affinity but low capacity, requiring a calculated four receptor sites per remnant particle [21] . In contrast, LDL binds to the apolipoprotein-B100/E receptor via apolipoprotein B100 with high affinity and high capacity, with only one binding site required per particle. Therefore chylomicron-remnant removal may be compromised at lower cellular apolipoprotein-Bl00/E receptor densities.
We attempted to identify a receptor-removal process which was distinct from the apolipoprotein-Bl00/E receptor system, by comparing the clearances of chylomicron-like emulsions and cholesterol-free particles. Chylomicron-like emulsion particles which lack unesterified cholesterol are lipolysed normally, but are not removed by high-affinity remnant-removal mechanisms [12] . If a second receptor pathway for chylomicron remnants existed, a difference in clearance would be found between normal emulsions and those lacking cholesterol when injected into homozygote WHHL rabbits. However, rates of clearance of the two emulsion types were the same in the homozygote and heterozygote WHHL rabbits (Fig. 5 ). Our findings in the heterozygote and homozygote rabbits can be explained by the absence of receptor-mediated removal of chylomicron remnants. Our findings do not support the existence of a second highaffinity removal mechanism for chylomicron remnants.
